tiprankstipranks
Zelira Therapeutics (AU:ZLD)
ASX:ZLD
Australian Market

Zelira Therapeutics (ZLD) Financial Statements

Compare
5 Followers

Zelira Therapeutics Financial Overview

Zelira Therapeutics's market cap is currently $5.56M. The company's EPS TTM is AU$-3.222; its P/E ratio is ―; Zelira Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 94.95KAU$ 301.12KAU$ 1.54MAU$ 663.32KAU$ 0.00
Gross ProfitAU$ 10.28KAU$ -3.22MAU$ -5.72MAU$ -39.16KAU$ -275.05K
Operating IncomeAU$ -5.94MAU$ -7.41MAU$ -13.41MAU$ -9.65MAU$ -7.84M
EBITDAAU$ -36.44MAU$ -6.87MAU$ -12.83MAU$ -9.18MAU$ -7.71M
Net IncomeAU$ -36.57MAU$ -5.57MAU$ -11.95MAU$ -8.55MAU$ -7.02M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 586.16KAU$ 146.21KAU$ 2.75MAU$ 4.97MAU$ 1.70M
Total AssetsAU$ 5.18MAU$ 33.89MAU$ 37.70MAU$ 39.37MAU$ 35.79M
Total DebtAU$ 5.95MAU$ 437.90KAU$ 500.91KAU$ 551.08KAU$ 632.32K
Net DebtAU$ 5.36MAU$ 291.70KAU$ -2.25MAU$ -4.42MAU$ -1.06M
Total LiabilitiesAU$ 9.36MAU$ 2.18MAU$ 2.01MAU$ 1.54MAU$ 1.24M
Stockholders' EquityAU$ -4.51MAU$ 31.80MAU$ 35.20MAU$ 37.83MAU$ 34.55M
Cash Flow
Free Cash FlowAU$ -4.39MAU$ -7.25MAU$ -9.43MAU$ -8.62MAU$ -6.95M
Operating Cash FlowAU$ -4.39MAU$ -7.25MAU$ -9.43MAU$ -8.62MAU$ -6.94M
Investing Cash FlowAU$ 919.74KAU$ 2.83MAU$ -207.78KAU$ 1.38MAU$ 1.11M
Financing Cash FlowAU$ 3.92MAU$ 1.77MAU$ 7.10MAU$ 10.53MAU$ 4.50M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

Zelira Therapeutics Debt to Assets

Zelira Therapeutics Cash Flow

Zelira Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis